Geron Corporation (0IV3.L)

USD 1.3

(-12.19%)

Inventory Summary of Geron Corporation

  • Geron Corporation's latest annual inventory in 2023 was - USD , up 100.0% from previous year.
  • Geron Corporation's latest quarterly inventory in 2024 Q2 was 774 Thousand USD , down 0.0% from previous quarter.
  • Geron Corporation reported annual inventory of -3.14 Million USD in 2022, down -124.73% from previous year.
  • Geron Corporation reported annual inventory of -1.39 Million USD in 2021, down -93.77% from previous year.
  • Geron Corporation reported quarterly inventory of 774 Thousand USD for 2024 Q2, down 0.0% from previous quarter.
  • Geron Corporation reported quarterly inventory of -1.59 Million USD for 2023 Q1, up 49.24% from previous quarter.

Annual Inventory Chart of Geron Corporation (2023 - 1996)

Historical Annual Inventory of Geron Corporation (2023 - 1996)

Year Inventory Inventory Growth
2023 - USD 100.0%
2022 -3.14 Million USD -124.73%
2021 -1.39 Million USD -93.77%
2020 -722 Thousand USD 9.98%
2019 -802 Thousand USD 31.34%
2018 -1.16 Million USD -167.89%
2017 -436 Thousand USD 8.21%
2016 -475 Thousand USD 60.61%
2015 -1.2 Million USD -25.23%
2014 -963 Thousand USD 0.0%
2013 - USD 100.0%
2012 -752 Thousand USD 0.0%
2011 - USD 100.0%
2010 -1.79 Million USD -36.49%
2009 -1.31 Million USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%
2005 - USD 0.0%
2004 - USD 0.0%
2003 - USD 0.0%
2002 - USD -100.0%
2001 530 Thousand USD 0.0%
2000 - USD 0.0%
1999 - USD 0.0%
1998 - USD 0.0%
1997 - USD 0.0%
1996 - USD 0.0%

Peer Inventory Comparison of Geron Corporation

Name Inventory Inventory Difference
uniQure N.V. 12.02 Million USD 100.0%
Agios Pharmaceuticals, Inc. 19.07 Million USD 100.0%
Amicus Therapeutics, Inc. 59.69 Million USD 100.0%
Atara Biotherapeutics, Inc. 9.7 Million USD 100.0%
bluebird bio, Inc. 22.91 Million USD 100.0%
Cara Therapeutics, Inc. 2.82 Million USD 100.0%
Imunon, Inc. - USD NaN%
Editas Medicine, Inc. - USD NaN%
IQVIA Holdings Inc. - USD NaN%
Mettler-Toledo International Inc. 385.86 Million USD 100.0%
Myriad Genetics, Inc. 20.1 Million USD 100.0%
Neurocrine Biosciences, Inc. 38.3 Million USD 100.0%
Supernus Pharmaceuticals, Inc. 77.4 Million USD 100.0%
Verastem, Inc. - USD NaN%
Walgreens Boots Alliance, Inc. 8.32 Billion USD 100.0%
Waters Corporation 516.23 Million USD 100.0%
Thermo Fisher Scientific Inc. 5.08 Billion USD 100.0%
Biogen Inc. 2.52 Billion USD 100.0%
Nektar Therapeutics 16.1 Million USD 100.0%
Perrigo Company plc 1.14 Billion USD 100.0%
Dynavax Technologies Corporation 53.29 Million USD 100.0%
Illumina, Inc. 587 Million USD 100.0%
Corbus Pharmaceuticals Holdings, Inc. - USD NaN%
Iovance Biotherapeutics, Inc. 10.37 Million USD 100.0%
Heron Therapeutics, Inc. 42.11 Million USD 100.0%
Unity Biotechnology, Inc. - USD NaN%
BioMarin Pharmaceutical Inc. 1.1 Billion USD 100.0%
Sangamo Therapeutics, Inc. - USD NaN%
Evolus, Inc. 10.99 Million USD 100.0%
Adicet Bio, Inc. - USD NaN%
Aclaris Therapeutics, Inc. - USD NaN%
Regeneron Pharmaceuticals, Inc. 2.58 Billion USD 100.0%
Esperion Therapeutics, Inc. 65.62 Million USD 100.0%
FibroGen, Inc. 41.56 Million USD 100.0%
Agilent Technologies, Inc. 1.03 Billion USD 100.0%
OPKO Health, Inc. 65.69 Million USD 100.0%
Homology Medicines, Inc. - USD NaN%
Alnylam Pharmaceuticals, Inc. 89.14 Million USD 100.0%
Exelixis, Inc. 17.32 Million USD 100.0%
Viking Therapeutics, Inc. - USD NaN%
Anavex Life Sciences Corp. - USD NaN%
Intellia Therapeutics, Inc. - USD NaN%
Zoetis Inc. 2.56 Billion USD 100.0%
Axsome Therapeutics, Inc. 15.13 Million USD 100.0%
Abeona Therapeutics Inc. -2.44 Million USD 100.0%
Vertex Pharmaceuticals Incorporated 738.8 Million USD 100.0%
Kala Pharmaceuticals, Inc. - USD NaN%
Ionis Pharmaceuticals, Inc. 28.42 Million USD 100.0%
Sarepta Therapeutics, Inc. 322.85 Million USD 100.0%
Corcept Therapeutics Incorporated 7.73 Million USD 100.0%
Halozyme Therapeutics, Inc. 127.6 Million USD 100.0%
Blueprint Medicines Corporation 21.22 Million USD 100.0%
Insmed Incorporated 83.24 Million USD 100.0%
TG Therapeutics, Inc. 39.82 Million USD 100.0%
Incyte Corporation 62.97 Million USD 100.0%
Emergent BioSolutions Inc. 328.9 Million USD 100.0%